肝脏局灶性实性病变的影像学诊断思路

doi:10.3969/j.issn.1672-5069.2018.04.002

Abstract

Wang Wentao, Rao Shengxiang. Focal solid liver lesions: Imaging diagnosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 493-495.

[1] Galanski M,Jordens S,Weidemann J.Diagnosis and differential diagnosis of benign liver tumors and tumor-like lesions. Chirurg,2008,79(8):707-721.
[2] Cogley JR,Miller FH.MR imaging of benign focal liver lesions. Radiol Clin North Am,2014,52(4):657-682.
[3] Ba-Ssalamah A,Baroud S,Bastati N,et al.MR imaging of benign focal liver lesions. Magn Reson Imaging Clin N Am,2010,18(3):403-419.
[4] Fowler KJ,Brown JJ,Narra VR.Magnetic resonance imaging of focal liver lesions:approach to imaging diagnosis. Hepatology,2011,54(6):2227-2237.
[5] 宋彬. 肝脏常见病变的影像诊断思路. 放射学实践,2017,23(2):114-117.
[6] Xie L,Guang Y,Ding H,et al.Diagnostic value of contrast-enhanced ultrasound,computed tomography and magnetic resonance imaging for focal liver lesions:a Meta-analysis. Ultrasound Med Biol,2011,37(6):854-861.
[7] 饶圣祥,胡道予,宦怡,等. 肝胆特异性MRI对比剂钆塞酸二钠临床应用专家共识. 临床肝胆病杂志,2016,34(12):2236-2241.
[8] Elsayes KM, Hooker JC,Agrons MM,et al.2017 version of LI-RADS for CT and MR imaging: An Update. Radiographics,2017,37(7):1994-2017.
[9] Choi JY,Lee JM,Sirlin CB.CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents,hepatobiliary agents,and ancillary imaging features. Radiology,2014,273(1):30-50.
[10] Kitao A,Matsui O,Yoneda N,et al.Hepatocellular carcinoma with beta-catenin mutation: Imaging and pathologic characteristics. Radiology,2015,275(3):708-717.
[11] Roth CG,Mitchell DG.Hepatocellular carcinoma and other hepatic malignancies: MR imaging. Radiol Clin North Am,2014,52(4):683-707.
[12] Choi SY,Kim SH,Park CK,et al.Imaging features of gadoxetic acid-enhanced and diffusion-weighted MR imaging for identifying cytokeratin 19-positive hepatocellular carcinoma:A retrospective sbservational study. Radiology,2018,286(3):897-908.
[13] Choi SY,Kim YK,Min JH,et al. Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging. Eur Radiol,2018[ahead of print].
[14] Caseiro-Alves F,Brito J, raujo AE,et al. Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis. Eur Radiol,2007,17(6):1544-1554.
[15] 于国,侯宁,陈玲红,等. 肝局灶性结节性增生18例病理诊断和鉴别诊断. 诊断病理学杂志,2002,23(4):24-26.
[16] Katabathina VS,Menias CO,Shanbhogue AK, et al.Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics, 2011,31(6):1529-1543.
[17] Laumonier H, Bioulac-Sage P,Laurent C,et al.Hepatocellular adenomas:magnetic resonance imaging features as a function of molecular pathological classification. Hepatology,2008,48(3):808-818.

Focal solid liver lesions: Imaging diagnosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[4]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[5]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[6]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[7]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[8]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[9]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[10]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[11]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[12]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[13]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[14]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.
[15]	Zhang Junfei, Xu Heming, Song Haiyan, et al. Autoimmune hepatitis-primary biliary cholangitis overlap syndrome:poor diagnostic sensitivity of Paris' criteria in Chinese patients [J]. Journal of Practical Hepatology, 2019, 22(4): 537-540.